Last few years the function of circular ANRIL has also been gradually explored, and with the progression of atherosclerosis, the expression level of circular ANRIL in plaque lesion tissue gradually decreases [63,64]. The gene discussed is CDKN2B-AS1; the disease is atherosclerosis.